AI assistant
Sending…
Celldex Therapeutics, Inc. — Director's Dealing 2015
Aug 26, 2015
31801_dirs_2015-08-26_1e05dc34-b3af-4628-9aeb-1ad07cca6c4f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Celldex Therapeutics, Inc. (CLDX)
CIK: 0000744218
Period of Report: 2015-08-25
Reporting Person: ELLBERGER LARRY (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-08-25 | Common Stock, par value $0.001 | P | 5000 | $14.00 | Acquired | 53500 | Direct |
More from Celldex Therapeutics, Inc.
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
May 7
Major Shareholding Notification
2026
May 6
Major Shareholding Notification
2026
Apr 29
Annual Report
2026
Apr 29
Proxy Solicitation & Information Statement
2026
Apr 29
Prospectus
2026
Apr 2
Regulatory Filings
2026
Apr 2
Prospectus
2026
Apr 1
Major Shareholding Notification
2026
Mar 26